Helmut Gohlke

Summary

Affiliation: Herz-Zentrum Bad Krozingen
Country: Germany

Publications

  1. ncbi [Nutrition and body weight]
    H Gohlke
    Klinische Kardiologie II Herz Zentrum Bad Krozingen Südring 15 79189 Bad Krozingen, Germany
    Z Kardiol 91:12-24. 2002
  2. ncbi CARRISMA: a new tool to improve risk stratification and guidance of patients in cardiovascular risk management in primary prevention
    Helmut Gohlke
    Klinische Kardiologie II, Herz Zentrum, Bad Krozingen, Germany
    Eur J Cardiovasc Prev Rehabil 14:141-8. 2007
  3. ncbi [Total risk for cardiovascular disease. At what point is medical prophylactic medication useful?]
    H Gohlke
    Klinische Kardiologie II, Herz Zentrum Bad Krozingen, Südring 15, 79189 Bad Krozingen, Germany
    Z Kardiol 94:III/6-10. 2005
  4. ncbi [Nutrition]
    H Gohlke
    Klinische Kardiologie II, Herz Zentrum Bad Krozingen, Südring 15, 79189 Bad Krozingen, Germany
    Z Kardiol 94:III/15-21. 2005
  5. ncbi [Recommendations for prevention and evidence-based medicine]
    H Gohlke
    Klinische Kardiologie II, Herz-Zentrum Bad Krozingen, , 79185 Bad Krozingen, Germany
    Z Kardiol 94:III/1-5. 2005
  6. ncbi [Possible ways of managing cardiovascular prevention: polypharmacy, additional payment or application of evidence based medicine?]
    H Gohlke
    Herz Zentrum Bad Krozingen
    Internist (Berl) 46:698-705. 2005
  7. ncbi Cardiovascular prevention in clinical practice (ESC and German guidelines 2007)
    Helmut Gohlke
    1Herz Zentrum Bad Krozingen, Bad Krozingen, Germany
    Herz 34:4-14. 2009
  8. ncbi [Lifestyle modification - is it worth it?]
    Helmut Gohlke
    Herz Zentrum, Bad Krozingen, Germany
    Herz 29:139-44. 2004
  9. ncbi [Primary prevention of cardiovascular disease]
    H Gohlke
    Klinische Kardiologie II, Herz-Zentrum Bad Krozingen
    Dtsch Med Wochenschr 130:38-43. 2005
  10. ncbi [New aspects in the management of asymptomatic patients with mitral regurgitation]
    Christa Gohlke-Bärwolf
    Herz Zentrum Bad Krozingen
    Herz 31:38-46. 2006

Detail Information

Publications15

  1. ncbi [Nutrition and body weight]
    H Gohlke
    Klinische Kardiologie II Herz Zentrum Bad Krozingen Südring 15 79189 Bad Krozingen, Germany
    Z Kardiol 91:12-24. 2002
    ..Fruits, vegetables and whole grain products are important components of this diet, which lowers the coronary event rate, increases longevity and is associated with a low rate of malignancies and osteoporosis...
  2. ncbi CARRISMA: a new tool to improve risk stratification and guidance of patients in cardiovascular risk management in primary prevention
    Helmut Gohlke
    Klinische Kardiologie II, Herz Zentrum, Bad Krozingen, Germany
    Eur J Cardiovasc Prev Rehabil 14:141-8. 2007
    ..However, body mass index (BMI), physical activity and smoking (cigarettes/day) are not or not quantitatively represented in the risk stratification system...
  3. ncbi [Total risk for cardiovascular disease. At what point is medical prophylactic medication useful?]
    H Gohlke
    Klinische Kardiologie II, Herz Zentrum Bad Krozingen, Südring 15, 79189 Bad Krozingen, Germany
    Z Kardiol 94:III/6-10. 2005
    ..Risk stratification with estimation of the NNT is therefore important for the decision to treat or not to treat...
  4. ncbi [Nutrition]
    H Gohlke
    Klinische Kardiologie II, Herz Zentrum Bad Krozingen, Südring 15, 79189 Bad Krozingen, Germany
    Z Kardiol 94:III/15-21. 2005
    ..These dietary habits are associated with a low rate of neoplasm and of osteoporosis. The recommendation for this type of diet is a class-I recommendation...
  5. ncbi [Recommendations for prevention and evidence-based medicine]
    H Gohlke
    Klinische Kardiologie II, Herz-Zentrum Bad Krozingen, , 79185 Bad Krozingen, Germany
    Z Kardiol 94:III/1-5. 2005
  6. ncbi [Possible ways of managing cardiovascular prevention: polypharmacy, additional payment or application of evidence based medicine?]
    H Gohlke
    Herz Zentrum Bad Krozingen
    Internist (Berl) 46:698-705. 2005
    ..Individual risk stratification is the basis for pharmacological prevention of cardiovascular events. The concept of the polypill has to be tested in controlled randomised studies...
  7. ncbi Cardiovascular prevention in clinical practice (ESC and German guidelines 2007)
    Helmut Gohlke
    1Herz Zentrum Bad Krozingen, Bad Krozingen, Germany
    Herz 34:4-14. 2009
    ..In patients after myocardial infarction with an ejection fraction of < 40%, ACE inhibitors and beta-blocker should be started. Influenza vaccination improves prognosis in high-risk patients...
  8. ncbi [Lifestyle modification - is it worth it?]
    Helmut Gohlke
    Herz Zentrum, Bad Krozingen, Germany
    Herz 29:139-44. 2004
    ..A nationwide improvement in lifestyle could result in a significant decrease in health care expenditures and could also have an important role in preventing or delaying coronary artery disease...
  9. ncbi [Primary prevention of cardiovascular disease]
    H Gohlke
    Klinische Kardiologie II, Herz-Zentrum Bad Krozingen
    Dtsch Med Wochenschr 130:38-43. 2005
  10. ncbi [New aspects in the management of asymptomatic patients with mitral regurgitation]
    Christa Gohlke-Bärwolf
    Herz Zentrum Bad Krozingen
    Herz 31:38-46. 2006
    ..Clinical assessment together with echocardiography and exercise hemodynamics determine the optimal timing of surgery in asymptomatic patients with severe MI...
  11. ncbi Cardiovascular prevention in patients with diabetes and prediabetes
    Matteo Anselmino
    Cardiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Herz 33:170-7. 2008
    ..Reference is made to the recently published European guidelines for diabetes, prediabetes and cardiovascular disease issued by the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)...
  12. ncbi Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
    Lars Ryden
    Department of Cardiology, Karolinska University Hospital, Sweden
    Eur Heart J 28:88-136. 2007
  13. ncbi Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA-study
    Bernhard Rauch
    Herzzentrum, Klinikum der Stadt Ludwigshafen, Ludwigshafen, Germany
    Cardiovasc Drugs Ther 20:365-75. 2006
    ..The results of the study are therefore expected for the beginning of 2008, when all patients will have completed the 12-months follow up-period...
  14. ncbi [Return to work after cardiologic rehabilitation]
    Jacqueline Müller-Nordhorn
    Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Universitatsklinikum Charite, Humboldt Universitat zu Berlin
    Soz Praventivmed 48:370-8. 2003
    ..The objectives of the present study were to determine prospectively return to work and its predictors in patients after cardiac rehabilitation...
  15. ncbi Quantitating loss of life by smoking a single cigarette
    Helmut Gohlke
    Clin Res Cardiol 96:522-3. 2007